Page 47 - REBRAME - Revista Brasileira de Medicina de Emergência
P. 47

BRAZILIAN JOURNAL OF EMERGENCY MEDICINE  VOLUME 03 | NÚMERO 1 / 39-44


         As with other causes of respiratory insufficiency, EVALI    6.   Caponnetto P, Campagna D, Cibella F, et al.
         is treated early with corticosteroids and antimicrobial   EffiCiency and Safety of aneLectronic cigAreTte
         therapy [12] . Corticosteroids were the treatment of choice in   (ECLAT) as tobacco cigarettes substitute: a prospective
          most case series, with satisfactory results [30] . There are still   12-month randomized control design study.PLoS One.
         no recommendations for doses and duration of treatment,   2013;8(6):e66317.
         with discharge only if clinical stability is guaranteed [29] .
                                                                7.   Kalkhoran S, Glantz SA. E-cigarettes and smoking
                                                                   cessation in real-world and clinical settings: a
         CONCLUSIONS                                               systematic review and meta-analysis.Lancet Respir
                                                                   Med.2016;4(2):116–128.
         EVALI is a recent pathology with a nonspecific clinical
         presentation, being diagnosed mainly through a recent    8.   Perrine CG, Pickens CM, Boehmer TK, et al.
         history of vaping and radiological exams with consistent   Characteristics of a multistate outbreak of lung injury
         findings.                                                 associated with e-cigarette use, or vaping – United
                                                                   States, 2019. MMWR Morb Mortal Wkly Rep 2019;
         Therefore, with the increasing use of electronic cigarettes,   68: 860-864. doi: 10.15585/mmwr.mm6839e1.
         EVALI becomes an important etiology to be considered in
         cases of respiratory failure, especially among young people.    9.   Lewis N, McCaffrey K, Sage K, et al. E-cigarette Use, or
         However, the scientific literature is still limited by the non-  Vaping, Practices and Characteristics Among Persons
         standardization of these devices, making it impossible to   with Associated Lung Injury – Utah, April-October
         identify all the substances involved in the pathophysiology   2019. MMWR Morb Mortal Wkly Rep 2019; 68: 953-
         of the disease.                                           956. doi: 10.15585/mmwr.mm6842e1.
                                                               10.  Hajek P, Phillips-Waller A, Przulj D, et al. E-cigarettes
         REFERENCES                                                compared with nicotine replacement therapy within
                                                                   the UK Stop Smoking Services: the TEC RCT. Health
          1.   Bizoń M, Maciejewski D, Kolonko J. E-cigarette or   Technol Assess 2019; 23: 1-82
             vaping  product  use-associated  acute  lung  injury
             (EVALI) as a therapeutic problem in anaesthesiology   11.  Schier JG, Meiman JG, Layden J, et al. Severe
             and intensive care departments. Anaesthesiol          pulmonary disease associated with electronic-
             Intensive Ther. 2020;52(3):219-225. doi: 10.5114/     cigarette-product use - interim guidance.MMWR Morb
             ait.2020.97989. PMID: 32876409.                       MortalWkly Rep. 2019;68(36):787–790.

          2.   Oriakhi M. Vaping: An Emerging Health Hazard. Cureus.   12.  Siegel DA, Jatlaoui TC, Koumans EH, et al. Update:
             2020 Mar 26;12(3):e7421. doi: 10.7759/cureus.7421.    interim guidance for health care providers evaluating
             PMID: 32351806; PMCID: PMC7186084.                    and caring for patients with suspected e-cigarette, or
                                                                   vaping, product use associated lung injury - United
          3.   Lampos S, Kostenidou E, Farsalinos K, Zagoriti Z,   States, October2019.MMWR Morb Mortal Wkly Rep.
             Ntoukas A, Dalamarinis K, Savranakis P, Lagoumintzis   2019;68(41):919–927.
             G, Poulas K. Real-Time Assessment of E-Cigarettes
             and Conventional Cigarettes Emissions: Aerosol Size   13.  Krishnasamy VP, Hallowell BD, Ko JY, Board A,
             Distributions, Mass and Number Concentrations.        Hartnett KP,Salvatore PP, et al; Lung Injury Response
             Toxics. 2019; 7(3):45. https://doi.org/10.3390/       Epidemiology/SurveillanceTask  Force.  Update:
             toxics7030045                                         characteristics of a nationwide outbreak of e-ciga-rette,
                                                                   or vaping, product use–associated lung injury— United
          4.   El Dib R, Suzumura EA, Akl EA, et al. Electronic    States,August  2019–January  2020.  MMWR  Morb
             nicotine delivery systems and/or electronic non-      Mortal Wkly Rep 2020;69(3):90- 94
             nicotine delivery systems for tobacco smoking
             cessation or reduction: a systematic review and meta-  14.  Werner AK, Koumans EH, Chatham-Stephens K,
             analy-sis. BMJ Open 2017; 7: e012680. doi: 10.1136/   Salvatore PP, Armatas C, Byers P, Clark CR, Ghinai
             bmjopen-2016-012680                                   I, Holzbauer SM, Navarette KA, Danielson ML,
                                                                   Ellington  S, Moritz  ED,  Petersen  EE,  Kiernan EA,
          5.   Cobb NK, Solanki JN. E-Cigarettes, Vaping Devices, and   Baldwin GT, Briss P, Jones CM, King BA, Krishnasamy
             Acute Lung Injury. Respir Care. 2020 May;65(5):713-   V, Rose DA, Reagan-Steiner S; Lung Injury Response
             718. doi: 10.4187/respcare.07733. PMID: 32345762.     Mortality  Working  Group.  Hospitalizations  and






          42 |  REBRAME | REVISTA BRASILEIRA DE MEDICINA DE EMERGÊNCIA
   42   43   44   45   46   47   48   49   50   51   52